The metabolism of cytosine arabinoside as a predictive test for clinical response to the drug in acute myeloid leukaemia

Lack of cross-resistance between cytosine arabinoside and a new halogenated nucleoside analogue, 2-bromo-2?-deoxyadenosine in human acute myeloid leukaemia cells

Cancer Chemotherapy and Pharmacology ◽

10.1007/bf00253971 ◽

1987 ◽

Vol 20 (2) ◽

Cited By ~ 2

Author(s):

LuciaB. Pemble ◽

MichelleG. Lihou ◽

RaymondL. Blakley ◽

GaryP. Jamieson ◽

PeterJ. Smith

Keyword(s):

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Nucleoside Analogue ◽

Cytosine Arabinoside ◽

Cross Resistance ◽

Increased remissions from one course for intermediate-dose cytosine arabinoside and idarubicin in elderly acute myeloid leukaemia when combined with cladribine. A randomized population-based phase II study

10.1046/j.1365-2141.2003.04702.x ◽

2003 ◽

Vol 123 (5) ◽

pp. 810-818 ◽

Cited By ~ 34

Author(s):

Gunnar Juliusson ◽

Martin Höglund ◽

Karin Karlsson ◽

Christina Löfgren ◽

Lars Möllgård ◽

...

Keyword(s):

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Phase Ii ◽

Cytosine Arabinoside ◽

Phase Ii Study ◽

Population Based ◽

Acute Myeloid ◽

Intermediate Dose

Low-dose cytosine arabinoside regimen induced a complete remission with normal karyotypes in a case with hypoplastic acute myeloid leukaemia with No. 8-trisomy: in vitro and in vivo evidence for normal haematopoietic recovery

10.1111/j.1365-2141.1985.tb07442.x ◽

1985 ◽

Vol 60 (3) ◽

pp. 449-455 ◽

Cited By ~ 13

Author(s):

M. Tagawa ◽

J. Shibata ◽

M. Tomonaga ◽

T. Amenomori ◽

Y. Yoshida ◽

...

Keyword(s):

Complete Remission ◽

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Cytosine Arabinoside ◽

Low Dose ◽

Mitozantrone and cytosine arabinoside as first-line therapy in elderly patients with acute myeloid leukaemia

10.1111/j.1365-2141.1991.tb08049.x ◽

1991 ◽

Vol 79 (3) ◽

pp. 415-420 ◽

Cited By ~ 59

Author(s):

J. A. Liu Yin ◽

P. R. E. Johnson ◽

J. M. Davies ◽

N. G. Flanagan ◽

D. W. Gorst ◽

...

Keyword(s):

Elderly Patients ◽

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Cytosine Arabinoside ◽

First Line ◽

First Line Therapy ◽

Line Therapy ◽

Theranostic drug test incorporating the bone‐marrow microenvironment can predict the clinical response of acute myeloid leukaemia to chemotherapy

10.1111/bjh.16684 ◽

2020 ◽

Vol 189 (6) ◽

Cited By ~ 1

Author(s):

Sukhraj Pal S. Dhami ◽

Andrea Tirincsi ◽

Denis Baev ◽

Janusz Krawczyk ◽

John Quinn ◽

...

Keyword(s):

Bone Marrow ◽

Acute Myeloid Leukaemia ◽

Clinical Response ◽

Myeloid Leukaemia ◽

Bone Marrow Microenvironment ◽

Drug Test ◽

Haematology and Blood Transfusion / Hämatologie und Bluttransfusion - Acute Leukemias VIII ◽

Multi Centre Study of a Combination of Fludarabine Phosphate, Cytosine Arabinoside and Granulocyte Colony Stimulating Factor (FLAG) in Relapsed and Refractory Acute Myeloid Leukaemia and in De Novo RAEB-t

10.1007/978-3-642-18156-6_34 ◽

2001 ◽

pp. 196-200

Author(s):

S. Proctor

Keyword(s):

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Cytosine Arabinoside ◽

De Novo ◽

Colony Stimulating Factor ◽

Multi Centre Study ◽

Centre Study ◽

Fludarabine Phosphate ◽

Stimulating Factor ◽

Long-term follow-up of patients >=60 yr old with acute myeloid leukaemia treated with intensive chemotherapy. A randomised trial of aclarubicin vs. daunorubicin in combination with cytosine arabinoside and thioguanine

European Journal Of Haematology ◽

10.1034/j.1600-0609.2002.00423.x ◽

2002 ◽

Vol 68 (6) ◽

pp. 376-381 ◽

Cited By ~ 10

Author(s):

G. Oberg ◽

A. Killander ◽

M. Bjoreman ◽

G. Gahrton ◽

G. Grimfors ◽

...

Keyword(s):

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Cytosine Arabinoside ◽

Randomised Trial ◽

Intensive Chemotherapy ◽

Long Term Follow Up ◽

Successful modulation of high-dose cytosine arabinoside metabolism in acute myeloid leukaemia by haematopoietic growth factors: no effect of ribonucleotide reductase inhibitors fludarabine and gemcitabine

10.1046/j.1365-2141.2000.02056.x ◽

2000 ◽

Vol 109 (2) ◽

pp. 388-395 ◽

Cited By ~ 8

Author(s):

Jan Braess ◽

Christine Wegendt ◽

Gerlinde Jahns-Streubel ◽

Wolfgang Kern ◽

Susan Keye ◽

...

Keyword(s):

Growth Factors ◽

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Ribonucleotide Reductase ◽

Cytosine Arabinoside ◽

High Dose ◽

Reductase Inhibitors ◽

Ribonucleotide Reductase Inhibitors ◽

IN VITRO RESISTANCE TO CYTOSINE ARABINOSIDE, NOT TO DAUNORUBICIN, IS ASSOCIATED WITH THE RISK OF RELAPSE IN DE NOVO ACUTE MYELOID LEUKAEMIA

10.1046/j.1365-2141.1996.d01-1742.x ◽

1996 ◽

Vol 93 (4) ◽

pp. 903-910 ◽

Cited By ~ 38

Author(s):

Edwin Klumper ◽

Gert J. Ossenkoppele ◽

Rob Pieters ◽

Dieuwke R. Huismans ◽

Annemarie H. Loonen ◽

...

Keyword(s):

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Cytosine Arabinoside ◽

De Novo ◽

Risk Of Relapse ◽

Hypoplastic acute myeloid leukaemia with 7 years of complete remission by low-dose cytosine arabinoside therapy alone

European Journal Of Haematology ◽

10.1111/j.1600-0609.1995.tb00235.x ◽

2009 ◽

Vol 55 (1) ◽

pp. 59-60 ◽

Cited By ~ 1

Author(s):

H. Mori ◽

K. Fuchigami ◽

K. Nagai ◽

T. Kohno ◽

T. Maeda ◽

...

Keyword(s):

Complete Remission ◽

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Cytosine Arabinoside ◽

Low Dose ◽